書誌事項
- タイトル別名
-
- Study of the Efficacy in RA Patients Switching from Etanercept 25 mg Twice a Week to 50 mg Once a Week
この論文をさがす
抄録
We investigated the efficacy of switching from etanercept 25 mg administered subcutaneously twice a week (ETN25 T/W) to 50 mg once a week (ETN50 O/W) in patients with active rheumatoid arthritis (RA). In the questionnaire, there were patients who reported “increased pain” by switching to ETN50O/W, but many patients reported improved convenience in terms of “reduced administration”, “convenient storage” and “easier to remember administration”. No patient requested to switch back from ETN50O/W to ETN25T/W. The evaluation of efficacy before (0 week) and after (8, 16, 24 weeks) using Disease Activity Score 28 (DAS28-CRP) showed no significant difference. Based on our findings, we suggest that the change from ETN25T/W to ETN50O/W is a clinical treatment choice with high efficacy for most patients.
収録刊行物
-
- 医療薬学
-
医療薬学 38 (11), 723-728, 2012
一般社団法人日本医療薬学会
- Tweet
詳細情報 詳細情報について
-
- CRID
- 1390282679752532224
-
- NII論文ID
- 130004894795
-
- ISSN
- 18821499
- 1346342X
-
- 本文言語コード
- ja
-
- データソース種別
-
- JaLC
- Crossref
- CiNii Articles
- KAKEN
-
- 抄録ライセンスフラグ
- 使用不可